University of Michigan
Ann Arbor, Michigan, 48109, United States
NCT Number: NCT04676698
This trial will be open to all Michigan Medicine Department of Family Medicine faculty, resident, or staff.
The intervention will consist of asking participants the "3 Good Things" based on positive psychology theory. Participants will be asked to list three things that went well that day and to consider their role in these outcomes. Pre and post surveys will be completed to evaluate this intervention.
At the end of the trial the study team will also select a limited number of entries from participants to share some of the "good things" which people listed. These will be edited to ensure writer anonymity and participants will be informed of this plan in the study introduction.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Ann Arbor, Michigan, 48109, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The treatment phase will last 3 weeks. However, participants will complete surveys at baseline and up to 6 months. At the end of the trial the study team will also select a limited number of entries from participants to share some of the "good things" which people listed. These will be edited to ensure writer anonymity and participants will be informed of this plan in the study introduction.
Surveys will be completed for 3 months prior to treatment and then after treatment.
Time frame: Pre-Treatment (baseline), up to 6 months
This is a 10 item survey to measure positive and negative affect. Responses include; very slightly or not at all, a little, quite a bit, and extremely. Higher scores of Positive Affect (PA) subscale represent higher positive affect higher scores of Negative affect (NA) subscale represent higher negative affect.
Time frame: Pre-Treatment (baseline), up to 6 months
This is a 1 question item to assess participants physical health ( 1=Excellent 2=good 3=fair 4=poor).
Time frame: Pre-Treatment (baseline), up to 6 months
This is a 1 question item to assess participants mental health ( 1=Excellent 2=good 3=fair 4=poor).
Time frame: Pre-Treatment (baseline), up to 6 months
The GAC is a 3-item self-report measure of state gratitude in which participants select, (1) A little (2) Moderately, Quite a bit (4), and Extremely (5).The total score on GAC ranges from 3 to 15, with higher score indicating greater state gratitude.
Time frame: Pre-Treatment (baseline) to 6 months
PHQ-9 scores reflect depression severity. Participants will select responses that include 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day. Ranges in scores are from 0-27 (Scores: 0-4 none, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe).
Time frame: Pre-Treatment (baseline), up to 6 months
This is a 5 question questionnaire in which participants select from 7 responses that are given a 1-7 scale from strongly disagree to strongly agree. Scoring ranges from 5-35 where 20 = neutral (the higher the score the more satisfaction).
Time frame: Pre-Treatment (baseline), up to 6 months
This is a 12 item questionnaire in which participants select from answers that include 1=definitely false 2=mostly false 3=mostly true 4=definitely true.
Scores range from 12-48 with higher scores indicating greater hope.
University of Michigan
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05931432
Anxiety Disorders, Behavior
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT04785677
Aberrant Motor Behavior in Dementia, Aggression
Tallahassee, Florida, United States
View Trial DetailsNCT06570993
Aberrant Motor Behavior in Dementia, Aggression
Auckland, Niue
View Trial DetailsNCT04070183
Anxiety, Anxiety Disorders
Indianapolis, Indiana, United States
View Trial Details